T. Welte (Hannover, Germany), R. Breyer-Kohansal (Vienna, Austria), H. Olschewski (Graz, Austria), T. Bauer (Berlin, Germany)
Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria
B. Lamprecht, L. Schirnhofer, B. Kaiser, S. Buist, M. Studnicka (Salzburg, Austria; Portland, United States Of America)
|  |
Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
P. R. Burgel, J. L. Paillasseur, D. Caillaud, I. Tillie-Leblond, P. Chanez, R. Escamilla, I. Court-Fortune, T. Perez, P. Carré, N. Roche (Paris, France)
| |
Clinical COPD questionnaire (CCQ) score and mortality
J. Sundh, C. Janson, K. Lisspers, S. Montgomery, B. Ställberg (Örebro, Uppsala, Sweden)
| |
The "rapid decliner" as a COPD phenotype associated with predominant emphysema
I. Cerveri, A. G. Corsico, A. Grosso, V. Ronzoni, B. Tripon, F. Albicini, F. Imberti, A. Foresi, C. Klersy, M. Luisetti (Pavia, Sesto San Giovanni, Italy)
| |
Can we assess COPD comorbidities by BODE index?
A. Corlateanu, G. Montanari, V. Botnaru (Chisinau, Republic Of Moldova; Modena, Italy)
| |
Cluster analysis revealed differences on quality of life and susceptibility to exacerbation between subpopulations of smokers including COPD
H. Hayashi, T. Ishii, N. Kokuho, M. Kurahara, T. Motegi, K. Hattori, K. Yamada, K. Kamio, A. Gemma, K. Kida (Tokyo, Japan)
|  |
Spirometry in UPLIFT®: Quality and reproducibility over time
W. Janssens, D. Liu, S. Kesten, D. P. Tashkin, B. R. Celli, M. Decramer (Leuven, Belgium; Ridgefield, Tustin, Los Angeles, Boston, United States Of America)
| |
Discriminative characteristics of the CAT score in stable COPD patients
E. Marchand, G. Maury (Yvoir, Belgium)
| |
Clinical-morphological changes in bronchial mucous membrane according to the III-IV COPD stages
I. Ivakh, O. Myronenko (Dnipropetrovsk, Ukraine)
| |
Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD
S. Langwieler, T. Wex, M. Peter, J. Schreiber (Magdeburg, Magdebuerg, Germany)
| |
Clinical characteristics of COPD with mild bronchiectasis
M. Kurahara, N. Kokuho, H. Hayashi, T. Ishii, T. Motegi, K. Hattori, K. Yamada, K. Kamio, A. Gemma, K. Kida (Tokyo, Japan)
| |
Bronchial hyperresponsiveness as phenotypic feature of COPD
I. Trofimenko, B. Chernyak (Irkutsk, Russian Federation)
| |
Skin autofluorescence is not a good marker for disease status in COPD
P. Gopal, E. Rutten, N. Reynaert, N. Ten Hacken, E. Wouters (Maastricht, Horn, Groningen, Netherlands)
| |
Association between comorbidities, disease severity and body mass index in COPD patients
M. Knorst, J. Nunes, L. Ries, J. Valentini, L. Rech (Porto Alegre, Brazil)
| |
Features of mucous membrane changes of bronchial tree at patients with COPD
T. Pertseva, I. Ivakh (Dnipropetrovsk, Ukraine)
| |
Gender difference in the perception of dyspnea in former smokers with COPD
V. Koblizek, S. Pracharova, P. Papousek (Hradec Kralove, Czech Republic)
| |
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
G. Vattanatt, S. Adiyodi (Trichur, India)
| |
Evaluation of the gas exchange abnormalities in COPD patients with the use of capnometry
Y. Feshchenko, L. Iashyna, S. Ishchuk (Kiev, Ukraine)
| |
The indices of body composition (IBC) in chronic obstructive pulmonary disease (COPD)
A. Makarevich, S. Lemesheuskaya, N. Vasieljeva (Minsk, Belarus)
| |
Evaluation of different domains of the Saint George‘s respiratory questionnaire (SGRQ) according to the severity levels of chronic obstructive pulmonary disease (COPD)
F. Athayde, R. Sampaio, B. Vieira, D. Vieira, R. Britto, V. Parreira (Belo Horizonte, Brazil)
| |